Michael Hansbury

2.3k total citations
18 papers, 860 citations indexed

About

Michael Hansbury is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Michael Hansbury has authored 18 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Michael Hansbury's work include Angiogenesis and VEGF in Cancer (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Michael Hansbury is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Michael Hansbury collaborates with scholars based in United States and Italy. Michael Hansbury's co-authors include Peggy Scherle, Jordan S. Fridman, Andrew P. Combs, Holly K. Koblish, Eddy W. Yue, Timothy C. Burn, Kevin Bowman, Robert D. Ladner, Kris Vaddi and Paola Zaratin and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Michael Hansbury

18 papers receiving 830 citations

Peers

Countries citing papers authored by Michael Hansbury

Since Specialization

Citations

This map shows the geographic impact of Michael Hansbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hansbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hansbury more than expected).

Fields of papers citing papers by Michael Hansbury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hansbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hansbury. The network helps show where Michael Hansbury may publish in the future.

Co-authorship network of co-authors of Michael Hansbury

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hansbury. A scholar is included among the top collaborators of Michael Hansbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hansbury. Michael Hansbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Abstract 1143: Development of a CDK2-selective small molecule inhibitor INCB123667 for the treatment of CCNE1hi breast cancers 2023 ·Cancer Research ·Saswati N. Chand, Michael Hansbury, Yvonne Lo, (unknown), Justine Carl, Cynthia Timmers, (unknown), Susan Wee, Sunkyu Kim	8
2	Abstract 4904: The BET inhibitor INCB054329 enhances the activity of checkpoint modulation in syngeneic tumor models 2016 ·Cancer Research ·Holly K. Koblish, Michael Hansbury, Leslie Hall, Liang-Chuan Wang, Yue Zhang, Maryanne Covington, Timothy C. Burn, Mark Rupar, Christine Gardiner, Thomas Condamine, (unknown), Matthew C. Stubbs, Eddy W. Yue, Richard Sparks, Thomas Maduskuie, Andrew P. Combs, Gregory Hollis, Reid Huber, (unknown), Peggy Scherle	4
3	Abstract C103: The combination of PI3kδ-selective inhibition and immunomodulation shows efficacy in solid tumor models 2015 ·Molecular Cancer Therapeutics ·Holly K. Koblish, Liang-Chuan Wang, Michael Hansbury, Yue Zhang, Gengjie Yang, Timothy C. Burn, Paul Waeltz, Mark Rupar, Eddy W. Yue, Brent Douty, Thomas Maduskuie, Nikoo Falahatpisheh, Yunlong Li, Andrew P. Combs, Gregory Hollis, Reid Huber, Peggy Scherle	5
4	Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents 2015 ·Journal for ImmunoTherapy of Cancer ·Liang‐Chuan S. Wang, Holly K. Koblish, Michael Hansbury, Yue Zhang, Gengjie Yang, Timothy C. Burn, Paul Waeltz, Mark Rupar, Eddy W. Yue, Brent Douty, Thomas Maduskuie, Nikoo Falahatpisheh, Yunlong Li, Andrew P. Combs, Gregory Hollis, Reid Huber, Peggy Scherle	2
5	Abstract 1336: Novel immunotherapeutic activity of JAK and PI3Kδ inhibitors in a model of pancreatic cancer 2015 ·Cancer Research ·Holly K. Koblish, Michael Hansbury, Liang‐Chuan S. Wang, Gengjie Yang, Taisheng Huang, Chu‐Biao Xue, Yunlong Li, Eddy W. Yue, Andrew P. Combs, Wenqing Yao, Reid Huber, Peggy Scherle	8
6	Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors 2010 ·Molecular Cancer Therapeutics ·Holly K. Koblish, Michael Hansbury, Kevin Bowman, Gengjie Yang, Brett A. Neilan, Patrick J. Haley, Timothy C. Burn, Paul Waeltz, Richard Sparks, Eddy W. Yue, Andrew P. Combs, Peggy Scherle, Kris Vaddi, Jordan S. Fridman	204
7	Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model 2009 ·Journal of Medicinal Chemistry ·Eddy W. Yue, Brent Douty, Brian Wayland, Michael J. Bower, Xiangdong Liu, Lynn Leffet, Qian Wang, Kevin Bowman, Michael Hansbury, Changnian Liu, Min Wei, Yanlong Li, Richard Wynn, Timothy C. Burn, Holly K. Koblish, Jordan S. Fridman, Brian Metcalf, Peggy Scherle, Andrew P. Combs	187
8	Optimization of triarylimidazoles for Tie2: Influence of conformation on potency 2007 ·Bioorganic & Medicinal Chemistry Letters ·Neil W. Johnson, M.A. Semones, Jerry L. Adams, Michael Hansbury, (unknown)	22
9	Pyridinylimidazole inhibitors of Tie2 kinase 2007 ·Bioorganic & Medicinal Chemistry Letters ·M.A. Semones, Yanhong Feng, Neil W. Johnson, Jerry L. Adams, (unknown), Michael Hansbury	30
10	Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer 2007 ·Clinical Cancer Research ·Jordan S. Fridman, Eian Caulder, Michael Hansbury, Xiangdong Liu, Genjie Yang, Qian Wang, Yvonne Lo, Bin‐Bing S. Zhou, (unknown), Sufi M. Thomas, Jennifer R. Grandis, Jin‐Cong Zhuo, Wenqing Yao, Robert Newton, Steven Friedman, Peggy Scherle, Kris Vaddi	114
11	TNF-α modulates angiopoietin-1 expression in rheumatoid synovial fibroblasts via the NF-κB signalling pathway 2005 ·Biochemical and Biophysical Research Communications ·B. B. Scott, Paola Zaratin, Aidan G. Gilmartin, Michael Hansbury, Antonio Colombo, (unknown), Julia Winkler, Jeffrey R. Jackson	39
12	Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts. 2002 ·PubMed ·Boyd B. Scott, Paola Zaratin, Antonio Colombo, Michael Hansbury, James D. Winkler, Jeffrey R. Jackson	71
13	dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae. 2002 ·PubMed ·(unknown), Michael Hansbury, Robert D. Ladner	45
14	Production and characterization of a Tie2 agonist monoclonal antibody 2001 ·Angiogenesis ·Michael Hansbury, Roberto F. Nicosia, (unknown), (unknown), (unknown)	12
15	Inhibitors of the p38 Mitogen-Activated Kinase Modulate IL-4 Induction of Low Affinity IgE Receptor (CD23) in Human Monocytes 1998 ·The Journal of Immunology ·Lisa A. Marshall, Michael Hansbury, Brian Bolognese, Rebecca J. Gum, Peter R. Young, Ruth J. Mayer	31
16	IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII) 1997 ·European Journal of Immunology ·Gary Christie, A. D. Barton, Brian Bolognese, Derek R. Buckle, Richard M. Cook, Michael Hansbury, Gregory P. Harper, Lisa A. Marshall, (unknown), Kevin Moulder, Paul R. Murdock, (unknown), (unknown), (unknown), Ruth J. Mayer	39
17	Affinity Purification and Comparative Analysis of Two Distinct Human Uracil-DNA Glycosylases 1996 ·Experimental Cell Research ·(unknown), Robert D. Ladner, Michael Hansbury, Mary C. Kosciuk, (unknown), Susan J. Muller	36
18	Induction of the lutropin/choriogonadotropin receptor in rat ovary during luteinization 1990 ·Biochemical and Biophysical Research Communications ·Michael Hansbury, (unknown), Michael J. Goldenthal	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact